No abstract available
MeSH terms
-
Adult
-
Aged
-
Androgen Antagonists / administration & dosage*
-
Chemoradiotherapy / mortality*
-
Chemoradiotherapy / statistics & numerical data*
-
Disease-Free Survival
-
Humans
-
Male
-
Middle Aged
-
Prevalence
-
Prostatic Neoplasms / mortality*
-
Prostatic Neoplasms / therapy*
-
Retrospective Studies
-
Risk Factors
-
Survival Rate
-
Treatment Outcome
-
United States / epidemiology